HOME >> MEDICINE >> NEWS
Mother's Milk: Nutrition And Nurture For Infants -- And The Best Defense Against Disease

From August 1 through 7, University of Pennsylvania Medical Center physicians and other health care providers serving mothers and infants will join in observing the sixth annual World Breastfeeding Week. The aim of the event, sponsored by La Leche League International and the World Alliance for Breastfeeding Action, is to raise public awareness of the many health and other advantages of breastfeeding to both babies and their mothers.

Breastfeeding is acknowledged by health professionals as the ideal source of nutrition for infants in almost every case. In addition, the nurturing relationship engendered by breastfeeding contributes to building a close bond between mother and child. Together, these factors promote the physical and emotional growth and development of the infant.

Long known to be true, too, is that breast-fed babies experience fewer and less serious incidences of disease and allergy than formula-fed babies. Gastrointestinal, respiratory, and middle-ear infections, in particular, are greatly reduced in breast-fed infants. In recent years, scientists at Penn and other institutions have sought to understand what it is about breast milk that makes it so protective for infants.

"What researchers have discovered is that breast milk is much more than just food," says Charles V. Clevenger, MD, PhD, an assistant professor of pathology and laboratory medicine. "It's also a bioactive compound containing antibodies that defend against infection and hormones and growth factors that direct the infant's immune system to develop fully and appropriately."

For example, Clevenger's studies have shown that the hormone prolactin, which is responsible for growth and differentiation of the breast during puberty, pregnancy, and lactation, also plays a significant role in stimulating immune-system cells in the infant. And while prolactin is primarily produced in the pituitary gland, Clevenger's team found that tissues in the breast ar
'"/>

Contact: Franklin Hoke
hokef@mail.med.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
31-Jul-1997


Page: 1 2 3

Related medicine news :

1. Mothers depression associated with increased risk of childs antisocial behavior
2. Mothers depression impedes babys development
3. Research news from the Friedman School of Nutrition Science and Policy at Tufts University
4. Research news from Tufts University, Friedman School of Nutrition Science and Policy: May 2004
5. Policy highlights from Tufts University Friedman School of Nutrition
6. Research news from Tufts University, Friedman School of Nutrition Science and Policy: April 2004
7. Nutrition education helps stretch meager food budgets
8. Policy highlights from Tufts University Friedman School of Nutrition
9. Research news from Tufts University, Friedman School of Nutrition Science and Policy: March 2004
10. AGA launches Obesity and Nutrition Education Initiative
11. Nutrition 21 seeks FDA approval of diabetes-related health claims

Post Your Comments:
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... the body,s system for repairing damage to the genetic ... as it may seem, those compounds are sparking optimism ... by a mutation in BRCA, a gene that made ... mutation. The compounds, termed PARP inhibitors, are the topic ... Chemical & Engineering News . C&EN is the ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...
(Date:6/19/2013)... 2013 Many trying-to-conceive couples seek ... necessary, according to a recent study ... The results of this research confirm what Fairhaven ... decade – that trying-to-conceive women would benefit from ... body weight. Fairhaven Health is a leading provider ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... 2013   Nektar Therapeutics (Nasdaq: NKTR ... liability (HAL) study for NKTR-181, a first-in-class, opioid ... brain.  This slow rate of entry is designed to reduce ... addiction to current opioid analgesics. 1 In the study ... to placebo in "drug liking" and "feeling high" scores and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
Cached News: